These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 16766364

  • 1. Interleukin-1beta influences the effect of infliximab on temporomandibular joint pain in rheumatoid arthritis.
    Kopp S, Alstergren P, Ernestam S, Nordahl S, Bratt J.
    Scand J Rheumatol; 2006; 35(3):182-8. PubMed ID: 16766364
    [Abstract] [Full Text] [Related]

  • 2. Reduction of temporomandibular joint pain after treatment with a combination of methotrexate and infliximab is associated with changes in synovial fluid and plasma cytokines in rheumatoid arthritis.
    Kopp S, Alstergren P, Ernestam S, Nordahl S, Morin P, Bratt J.
    Cells Tissues Organs; 2005; 180(1):22-30. PubMed ID: 16088130
    [Abstract] [Full Text] [Related]

  • 3. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M, Zwicker M, Villiger PM.
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [Abstract] [Full Text] [Related]

  • 4. Temporomandibular joint pressure pain threshold is systemically modulated in rheumatoid arthritis.
    Alstergren P, Fredriksson L, Kopp S.
    J Orofac Pain; 2008 Jan; 22(3):231-8. PubMed ID: 18780536
    [Abstract] [Full Text] [Related]

  • 5. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
    Kaneyama K, Segami N, Sun W, Sato J, Fujimura K.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
    [Abstract] [Full Text] [Related]

  • 6. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
    Nakahara H, Song J, Sugimoto M, Hagihara K, Kishimoto T, Yoshizaki K, Nishimoto N.
    Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
    [Abstract] [Full Text] [Related]

  • 7. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate.
    Seitz M, Loetscher P, Dewald B, Towbin H, Rordorf C, Gallati H, Gerber NJ.
    J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917
    [Abstract] [Full Text] [Related]

  • 8. Differences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritis.
    De Benedetti F, Pignatti P, Gerloni V, Massa M, Sartirana P, Caporali R, Montecucco CM, Corti A, Fantini F, Martini A.
    J Rheumatol; 1997 Jul; 24(7):1403-9. PubMed ID: 9228145
    [Abstract] [Full Text] [Related]

  • 9. Insufficient endogenous control of tumor necrosis factor-alpha contributes to temporomandibular joint pain and tissue destruction in rheumatoid arthritis.
    Alstergren P, Kopp S.
    J Rheumatol; 2006 Sep; 33(9):1734-9. PubMed ID: 16960936
    [Abstract] [Full Text] [Related]

  • 10. Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.
    van Oosterhout M, Levarht EW, Sont JK, Huizinga TW, Toes RE, van Laar JM.
    Ann Rheum Dis; 2005 Apr; 64(4):537-43. PubMed ID: 15769913
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-1beta, interleukin-1 receptor antagonist, and interleukin-1 soluble receptor II in temporomandibular joint synovial fluid from patients with chronic polyarthritides.
    Alstergren P, Benavente C, Kopp S.
    J Oral Maxillofac Surg; 2003 Oct; 61(10):1171-8. PubMed ID: 14586853
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade.
    Ingegnoli F, Fantini F, Favalli EG, Soldi A, Griffini S, Galbiati V, Meroni PL, Cugno M.
    J Autoimmun; 2008 Sep; 31(2):175-9. PubMed ID: 18707846
    [Abstract] [Full Text] [Related]

  • 14. Proinflammatory cytokines synergistically enhance the production of chemokine ligand 20 (CCL20) from rheumatoid fibroblast-like synovial cells in vitro and serum CCL20 is reduced in vivo by biologic disease-modifying antirheumatic drugs.
    Kawashiri SY, Kawakami A, Iwamoto N, Fujikawa K, Aramaki T, Tamai M, Arima K, Kamachi M, Yamasaki S, Nakamura H, Tsurumoto T, Kono M, Shindo H, Ida H, Origuchi T, Eguchi K.
    J Rheumatol; 2009 Nov; 36(11):2397-402. PubMed ID: 19797510
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Impact of treatment with infliximab on serum cytokine profile of patients with rheumatoid and psoriatic arthritis.
    Amital H, Barak V, Winkler RE, Rubinow A.
    Ann N Y Acad Sci; 2007 Sep; 1110():649-60. PubMed ID: 17911480
    [Abstract] [Full Text] [Related]

  • 17. The tumor necrosis factor-{alpha}-blocking agent infliximab inhibits interleukin 1beta (IL-1beta) and IL-6 gene expression in human osteoblastic cells.
    Musacchio E, Valvason C, Botsios C, Ostuni F, Furlan A, Ramonda R, Modesti V, Sartori L, Punzi L.
    J Rheumatol; 2009 Aug; 36(8):1575-9. PubMed ID: 19567627
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Decreased ex vivo production of TNF-alpha and IL-8 by peripheral blood cells of patients with rheumatoid arthritis after infliximab therapy.
    Lun SW, Wong CK, Tam LS, Li EK, Lam CW.
    Int Immunopharmacol; 2007 Dec 15; 7(13):1668-77. PubMed ID: 17996676
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.